Related Experiment Video
Updated: May 2, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Approaches to comparative effectiveness research in multimorbid populations
Matthew L Maciejewski1, Elizabeth A Bayliss
1*Health Services Research and Development, Durham VA Medical Center †Department of Medicine, Division of General Internal Medicine, Duke University Medical Center, Durham, NC ‡Institute for Health Research, Kaiser Permanente, Denver §Department of Family Medicine, University of Colorado Denver, Aurora, CO.
Generating evidence for multiple chronic medical conditions (MCC) requires adapting comparative effectiveness research (CER) methods. This study explores alternative approaches for valid evidence to guide MCC patient care.
Area of Science:
- Health Services Research
- Clinical Epidemiology
- Biostatistics
Background:
- Multiple chronic medical conditions (MCC) affect a significant patient population, necessitating tailored evidence-based care.
- Current comparative effectiveness research (CER) methods are often designed for single diseases, limiting their applicability to MCC populations.
- There is an urgent need for robust evidence to guide the complex care of patients with MCC.
Purpose of the Study:
- To discuss the challenges and propose alternative methodological approaches for conducting CER in MCC populations.
- To initiate a dialogue on the most appropriate methods for generating evidence for MCC care.
- To identify strategies for developing meaningful outcome measures and aligning morbidity measurement with relevant outcomes in MCC research.
Main Methods:
- Review and discussion of experimental and quasi-experimental study designs for CER in MCC.
- Exploration of methods for estimating heterogeneity of treatment effects in diverse MCC patient groups.
- Consideration of strategies for developing and validating outcome measures relevant to multiple conditions.
Main Results:
- Standard CER methods may not be sufficient for MCC populations, requiring adaptation.
- Experimental and quasi-experimental designs offer potential but have limitations in MCC research.
- Developing meaningful outcome measures and aligning them with morbidity is crucial for valid CER in MCC.
Conclusions:
- Adapting and developing novel CER methods are essential for generating valid evidence for MCC patient care.
- Engaged dialogue among clinicians, methodologists, and patients is key to refining CER approaches for MCC.
- Recommendations for preferred methods in CER for MCC populations can be developed to fill critical knowledge gaps.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Bioequivalence of Drugs: Drugs with Multiple Indications
Analysis of Population Pharmacokinetic Data
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Dosage Regimens: Designs and Approaches
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
